NYSE:MDCM.D.C. Stock Price, Forecast & News

M.D.C.'s stock was trading at $33.96 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MDC shares have increased by 7.9% and is now trading at $36.65. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 4 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for M.D.C..

M.D.C. is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for M.D.C..

M.D.C. Holdings, Inc. (NYSE:MDC) posted its earnings results on Tuesday, May, 5th. The construction company reported $0.56 EPS for the quarter, missing the Zacks' consensus estimate of $0.69 by $0.13. The construction company had revenue of $697.10 million for the quarter, compared to analyst estimates of $733.88 million. M.D.C. had a return on equity of 13.48% and a net margin of 7.01%. The business's revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.64 earnings per share. View M.D.C.'s earnings history.

M.D.C. declared a quarterly dividend on Friday, April 3rd. Stockholders of record on Wednesday, May 6th will be paid a dividend of $0.33 per share on Wednesday, May 20th. This represents a $1.32 annualized dividend and a yield of 3.60%. The ex-dividend date of this dividend is Tuesday, May 5th. View M.D.C.'s dividend history.

7 brokerages have issued 12 month price targets for M.D.C.'s shares. Their forecasts range from $22.00 to $42.00. On average, they anticipate M.D.C.'s stock price to reach $32.00 in the next twelve months. This suggests that the stock has a possible downside of 12.7%. View analysts' price targets for M.D.C..

Press coverage about MDC stock has been trending extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. M.D.C. earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave media headlines about the construction company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news aboutM.D.C..

M.D.C. saw a decline in short interest in May. As of May 15th, there was short interest totaling 1,080,000 shares, a decline of 21.7% from the April 30th total of 1,380,000 shares. Based on an average daily trading volume, of 724,800 shares, the days-to-cover ratio is presently 1.5 days. Approximately 2.2% of the shares of the stock are short sold. View M.D.C.'s Current Options Chain.

Some companies that are related to M.D.C. include D. R. Horton (DHI), Lennar (LEN), NVR (NVR), PulteGroup (PHM), Toll Brothers (TOL), KB Home (KBH), Meritage Homes (MTH), TRI Pointe Group (TPH), Cavco Industries (CVCO), M/I Homes (MHO), Beazer Homes USA (BZH) and Hovnanian Enterprises (HOV). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Cisco Systems (CSCO), Home Depot (HD), Verizon Communications (VZ), NVIDIA (NVDA), Intel (INTC), CVS Health (CVS), Walt Disney (DIS), AT&T (T) and Procter & Gamble (PG).

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

M.D.C.'s stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.55%), State Street Corp (3.01%), Bank of New York Mellon Corp (2.13%), Vaughan Nelson Investment Management L.P. (1.35%), Geode Capital Management LLC (1.20%) and Advisory Research Inc. (0.70%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Michael Touff, Paris G Reece III, Raymond T Baker and Robert Nathaniel Martin. View institutional ownership trends for M.D.C..

MDC stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Morgan Stanley, Morgan Stanley, WINTON GROUP Ltd, William Blair Investment Management LLC, Schroder Investment Management Group, New York State Common Retirement Fund, and Invesco Ltd.. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, and Raymond T Baker. View insider buying and selling activity for M.D.C..

MDC stock was purchased by a variety of institutional investors in the last quarter, including Advisory Research Inc., Grantham Mayo Van Otterloo & Co. LLC, Bahl & Gaynor Inc., Natixis Advisors L.P., Acadian Asset Management LLC, State Street Corp, BlackRock Inc., and Comerica Bank. View insider buying and selling activity for M.D.C..

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MDC stock can currently be purchased for approximately $36.65.

M.D.C. has a market capitalization of $2.31 billion and generates $3.29 billion in revenue each year. The construction company earns $238.31 million in net income (profit) each year or $3.72 on an earnings per share basis. M.D.C. employs 1,656 workers across the globe.

The official website for M.D.C. is www.mdcholdings.com.

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]